Tuberculosis in HIV-Infected Children on Antiretroviral Therapy
Author Information
Author(s): Walter Elisabetta, Cotton Mark F, Rabie Helena, Schaaf H Simon, Walter Lourens O, Marais Ben J
Primary Institution: Department of Pediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa
Hypothesis
What is the clinical presentation and outcome of tuberculosis in HIV-infected children receiving HAART?
Conclusion
The study found a high incidence of tuberculosis among HIV-infected children, particularly before starting HAART, and suggests that earlier initiation of HAART may reduce TB-related morbidity and mortality.
Supporting Evidence
- 290 children were analyzed, with 137 TB episodes recorded.
- Mortality was lower in children on HAART compared to those not on HAART.
- 71% of TB episodes had a positive outcome.
Takeaway
Kids with HIV get sick from tuberculosis a lot, especially before they start their medicine. Giving them their medicine earlier can help them get better.
Methodology
A retrospective file review of HIV-infected children who started HAART at Tygerberg Children's Hospital from January 2003 to December 2005.
Potential Biases
Selection bias is unlikely as the hospital was the only access point for HAART during the study period.
Limitations
The study is limited by incomplete data and missing records.
Participant Demographics
Children aged <13 years, with a significant number having severe immunosuppression.
Statistical Information
P-Value
<0.0001
Confidence Interval
95% CI 12.5–22.4
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website